See also this year's filing and all EDGAR filings for this company.
PDF Report 0001302573_2014_Oncomed_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | No LiabilitiesAndStockholdersEquity node found | input.sec.calculation_linkbase.edgar_model_mapping | {'lase_node': None, 'equity_node': None, 'partners_cap_node': None, 'nodes': "NodeView(('AssetsCurrent', 'Assets', 'PropertyPlantAndEquipmentNet', 'OtherAssetsNoncurrent', 'CashAndCashEquivalentsAtCarryingValue', 'ShortTermInvestments', 'AccountsReceivableRelatedParties', 'PrepaidExpenseAndOtherAssetsCurrent', 'LiabilitiesCurrent', 'Liabilities', 'DeferredRevenueNoncurrent', 'DeferredRentCreditNoncurrent', 'AccruedIncomeTaxesNoncurrent', 'LiabilityForSharesIssuedWithRepurchaseRightsLessCurrentPortion', 'AccountsPayableCurrent', 'TaxesPayableCurrent', 'AccruedLiabilitiesCurrent', 'DeferredRevenueCurrent', 'DeferredRentCreditCurrent', 'LiabilityForSharesIssuedWithRepurchaseRights', 'ConvertiblePreferredStockWarrantLiability'))"} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001302573, Oncomed Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 318,744,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 4,641,000 |
| 3 | remainder_Assets | 10,300,000 |
| 4 | LiabilitiesCurrent | 62,017,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 153,546,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,630,000 |
| 9 | ResearchAndDevelopmentExpense | 50,048,000 |
| 10 | remainder_Expenses | 1,944,000 |
| 11 | remainder_Revenues | 37,779,000 |
| 12 | remainder_NetIncome | -228,000 |
| 13 | remainder_ComprehensiveNetIncome | -1,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 333,685,000 |
| 1 | Liabilities | 215,563,000 |
| 2 | Expenses | 63,622,000 |
| 3 | Revenues | 37,779,000 |
| 4 | StockholdersEquity | 118,122,000 |
| 5 | NetIncome | -26,071,000 |
| 6 | ComprehensiveNetIncome | -26,071,500 |
| 7 | BaseVar | 325,439,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.843 |
| 9 | EconomicCapitalRatio | 2.18 |